Enterprise Solutions Webinars

  1. Standing Out In The Crowded Biopharmaceutical Contract Manufacturing Market
    3/14/2019

    Differentiating one’s CDMO offering from competitors is an essential component of gaining awareness, familiarity, and being awarded business. When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time. 

  2. Singota Solutions—Focused on Faster
    2/27/2019

    This video introduces Singota Solutions, a CDMO focused on getting products to patients faster by being agile, accountable and transparent. A team of industry experts help virtual to large pharma clients reach preclinical and clinical milestones faster with shorter lead times and agile onsite operations. Services in formulation development, finishing and supply chain support Singota’s flagship aseptic filling operations. A gloveless robotic isolator provides highly repeatable and precise filling for high value drug products.

  3. Going Intensified, Connected Or Continuous?
    12/27/2018

    Hear how an adaptive and evolving platform of proven and novel technologies enables biomanufacturers to successfully accomplish their bioprocessing goals through either intensified, connected or continuous bioprocessing.

  4. Using Single-Use Technology To Enable Single-Pass Tangential Flow Filtration
    12/27/2018

    As the industry is looking to increase speed to market, reduce manufacturing resources and increase product safety, there has been a push to implement single-use technologies. Combining both SPTFF and single-use technology can be a powerful tool for the efficient manufacture of biologics.

  5. Cell Culture Scale-Up Using Stirred-Tank Single-Use Bioreactors
    12/12/2018

    This webinar discusses several scaling approaches, such as constant tip speed, kLa, and power number-based scale-up.

  6. Culture Of 3D Cell Aggregates In Perfusion
    12/12/2018

    This webcast reviews a research example for process development with the human tumor cell line H157, cultivated in stirred-tank mini bioreactors as 3D cell aggregates.

  7. Multivariate Data Analysis In Biopharmaceutical Development
    12/12/2018

    See applications of MVA and DoE in bioprocess development and how these powerful tools can be integrated in this live webcast.

  8. Optimizing A Biosimilar Production Process
    12/12/2018

    This webinar discusses a research project focused on determining if the three primary methods of production for a typical biosimilar (batch, fed-batch, and perfusion) may be simply and easily executed using a single, benchtop bioprocess control system.

  9. A Systematic Approach To Extractables And Leachables: A Review Of Guidance From The Industry
    12/11/2018

    This presentation discusses the basic definitions of extractables and leachables, including details from a case study done using prefilled syringes and a second using a single-use bag.

  10. Cell-Based Assays In A GMP Environment: Approaches For Clinical And Commercial Stability Studies
    12/11/2018

    This presentation demonstrates that in vitro, cell-based assays is an indispensable tool to quantify the biological activities, and to support the potency tests, for bio therapeutics.